Primrose Bio was proud to exhibit and present at the World Vaccine Congress 2025, held April 22–25 in Washington, D.C. Our team shared insights into next-generation solutions for biotherapeutics and vaccine manufacturing, highlighting our Prima RNApols™ platform for high-quality, streamlined, and cost-effective mRNA synthesis.
Advisor Khaled Yamout led two key sessions during the event:
- April 22 @ 11:40 AM – Working Group 11: Challenges in mRNA Manufacturing – Choosing the Right RNA Polymerase
- April 23 @ 4:40 PM – mRNA Synthesis with Improved RNA Polymerases: Prima RNApols™
At Booth 225, Louis J. Cantolupo and Jennifer Wittbold from our business development team engaged with attendees on how Primrose Bio supports complex manufacturing needs for emerging biologics.
